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Crystal Structure of I-Ak in Complex
with a Dominant Epitope of Lysozyme
them; the higher strength of alloreactivity to I-A relative
to I-E; the involvement of I-E in some regulatory sup-
pressive interactions; and differential pH effects on pep-
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New York, New York 10032 I-E a gene in both inbred strains of mice as well as
²Center for Immunology, Department of Pathology wild mice (Figueroa et al., 1989). These spontaneous
Washington University School of Medicine deletions do not lead to immunologic impairment in the
St. Louis, Missouri 63110 mice that harbor only I-A molecules. Other rodents have
been shown to lack the equivalent of the I-E molecule
(Nizetic et al., 1987). The reverse situation (i.e., deletion
Summary of I-A genes) has not been found, although mice bearing
I-E but not I-A have been genetically engineered (Cos-
We have determined the structure of murine MHC grove et al., 1992). A detailed structural understanding
class II I-Ak in complex with a naturally processed of the similarities and differences between I-A and the
peptide from hen egg lysozyme (HEL residues 50±62) paralogous I-E could help illuminate the respective roles
at 1.9 AÊ resolution. These results provide a structural these molecules play in peptide presentation and T cell
basis for the I-Ak peptide-binding motif. Binding is es- activation.
tablished by the deep burial of five anchor side chains The sequence motifs that explain peptide binding to
into specific pockets of the I-Ak binding groove, with I-A molecules have been difficult to ascertain. There has
a zen-like fit of an aspartic acid in the P1 pocket. We been uncertainty for both I-Ad and I-Ak, themost frequent
also show that in the I-Ak a chain, a bulge occurs in class II molecules analyzed, as to which are the critical
the first strand of the peptide-binding platform, an peptide side-chain interactions responsible for allele-
insertion probably common to all I-A and HLA-DQ al-
specific binding (Buus et al., 1987; Rudensky et al.,
leles. The I-Ak b chain has a deletion in the helical
1991). The immunogenic properties of the HEL proteinregion adjacent to the P7 pocket and an insertion in
have been analyzed and described extensively (Allenthe helical region neighboring the P1 pocket. As a
and Unanue, 1984; Adorini et al., 1988; Nelson et al.,result of these structural features, the extended HEL
1996c). In fact, the first direct evidence for MHC peptidepeptide dips low into the center of the I-Ak groove and
binding was described in this system (Babbitt et al.reaches toward solvent at its C-terminal end.
1985). A peptide corresponding to HEL residues 48±62
was shown to contain amino acid residues that con-Introduction
tacted the I-Ak molecule dispersed with residues that
contacted the TCR (Allen et al., 1987). Subsequently,In this report we present the high-resolution structural
the analysis of peptides selected from HEL processinganalysis of the class II major histocompatibility (MHC)
by antigen-presenting cells disclosed that 48±62 repre-molecule I-Ak incomplex with a covalently attached lyso-
sents a major immunodominant epitope. The analysiszyme peptide. All of the available structural information
for specific peptide binding to class II molecules comes of this and other naturally processed peptides extracted
from studies of human leukocyte antigen (HLA)±DR from I-Ak molecules of antigen-presenting cells dis-
(Stern et al., 1994; Ghosh et al., 1995; Dessen et al.,1997) closed several important features: a major acidic anchor
and its murine orthologue I-E (Fremont et al., 1996). The residue, usually four or five residues from the N-termi-
other main family of class II molecules, represented by nus, and peptides that were at least 14 residues in length
the human molecules HLA-DQ and HLA-DP and the (Nelson et al., 1992; Marrack et al., 1993; Nelson et al.,
mouse I-A, has until now resisted crystallographic char- 1996a, 1996b, 1996c).
acterization. I-A and I-E molecules have the same basic In this work we have produced a soluble complex of
features insofar as peptide loading and presentation, I-Ak covalently bound with an HEL peptide and have
although each interacts with distinctly different sets of solved its crystal structure at high resolution. In so do-
peptides. Whether I-A and I-E subserve different func- ing, we have uncovered several structural features
tions has long been argued (Figueroa et al., 1990; Cos- unique to the I-A family of class II molecules. Further-
grove et al., 1992). Issues that have been raised concern more, we have been able to delineate the structural
the binding of microbial superantigens to I-E, with the basis for the peptide-binding motif of I-Ak. In contrast
frequent deletion of T cell receptors (TCRs) binding to to peptides bound to I-E and DR, the HEL peptide is
bound deep in the middle of the I-Ak groove and extends
³Present address: Center for Immunology, Department of Pathol- upward at the C-terminal end of the peptide. The avail-
ogy, and Department of Biochemistry and Molecular Biophysics, ability of this structural information should prove useful
Washington University School of Medicine, St. Louis, Missouri
for the design and interpretation of a number of experi-63110.
ments investigating antigen processing and presen-§To whom correspondence should be addressed (e-mail: fremont@
immunology.wustl.edu). tation.
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Figure 1. Electron Density and Overall Fold
of the HEL Peptide Bound to I-Ak
(A) Electron density for the core of HEL (P21±
P9, HEL residues 51±60) is shown, as is part
of the first strand of the I-Ak a chain in the
b sheet platform (b1 strand, a6±a13). 2Fo2Fc
electron density was calculated for all reflec-
tions between 6 and 1.9 AÊ resolution and was
displayed as a map cover in the model-build-
ing program O (Jones et al., 1991). Carbon
atoms are demarcated in yellow, oxygen red,
and nitrogen blue in the structural model.
(B) A ribbon diagram (Carson, 1987) of HEL
bound to I-Ak. The I-Ak a chain is displayed
in cyan, the b chain in magenta, and HEL
in yellow. Side chains for HEL are displayed
(carbon in yellow, oxygen in red, and nitrogen
in blue), as are the three N-linked glycans
(GlcNAc residues in gray) attached to I-Ak res-
idues Asn a78 (cyan), Asn a118 (cyan), and
Asn b19 (magenta). The I-Ak/HEL complex
measures 85 AÊ 3 56 AÊ 3 44 AÊ , with the longest
dimension stretching from the base of the b2
domain to the C-terminus of the peptide.
Results and Discussion Laboratory [PDB] accession code 1IEA). The structure
has been refined at 1.9 AÊ resolution to an R value of
21.4% (Rfree 5 26.3%) with good geometry. The generalStructure Determination
I-Ak was expressed in CHO cells with glycosyl phospha- quality of the electron density maps for the modeled
I-Ak/HEL structure is excellent (Figure 1A). As expected,tidylinositol (GPI) tails replacing the transmembrane and
cytoplasmic regions of the a and b chains (see Experi- the overall fold of I-Ak is similar to that of other MHC
molecules, although many of the fine details are uniquemental Procedures). The HEL peptide was genetically
attached to the I-Ak b chain by a glycine/serine linker (Figure 1B), as will be discussed below.
(Kozono et al., 1994). Soluble complexes were obtained
by enzymatic cleavage of the GPI tails. Diffraction-qual- Structural Alignment
One of the hallmarks of MHC molecules is their highity crystals of I-Ak/HEL were obtained using conditions
similar to those used for both HLA-DR1 and I-Ek crystals degree of polymorphism in outbred populations. How-
ever, in contrast to other immunological receptors with a(Brown et al., 1993; Fremont et al., 1996). The crystals
belong to the tetragonal spacegroup P41212 with unit high degree of sequence variationÐnamely, antibodies
and TCRsÐMHC molecules have a very limited numbercell dimensions a 5 b 5 112.25 AÊ and c 5 99.72 AÊ .
These crystals have one I-Ak/HEL complex per asym- of insertions and deletions in their extracellular domains.
We were therefore suprised to find two sites of aminometric unit. Analysis of the crystal packing of I-Ak/HEL
indicates that no extensive dimeric interactions are acid insertion and one site of deletion in the crystal
structure of I-Ak relative to the canonical structures ofpresent as a result of crystallographic symmetry opera-
tions. I-E and HLA-DR. These observations led us to propose
a structure-based alignment of the sequences and toInitial phases for the structure determination were ob-
tained by molecular replacement using the atomic coor- introduce a new numbering scheme for I-A residues that
is consistent with I-E and HLA-DR residue numberingdinates of I-Ek (Protein Data Bank, Brookhaven National
Structure of an I-Ak/HEL Peptide Complex
307
and that follows the general scheme of previous align- alignment is established by treating I-E and HLA-DR
residues b65 and b66 as insertions relative to I-Ak. Topo-ments (Kabat et al., 1991). The structure-based se-
quence alignment presented in Figure 2 includes I-A logically, these residues form the highest crest above
the peptide in the MHC complex. Both of the recentlyinsertions at positions a9a in the a chain and b84a in
the b chain, along with an I-Ak b chain deletion at posi- described crystal structures of ab TCR bound to murine
and human class I reveal that the CDR3 loop of the TCRtions b65 and b66.
Bulge in the b1 Strand of the I-Ak a Chain b chain contacts this prominant feature as it reaches in
to connect with the peptide (Garboczi et al., 1996; Garcia(the a9a Insertion)
Immediately apparent in the structure of I-Ak is a bulge et al., 1996). In the I-Ak structure, the C-terminal half of
the H1 helix (b59±b64) is shifted toward the H2a helix byin the middle of the first strand of the a1 domain (Figures
1 and 2A). The main chain of I-Ak protrudes outward approximately 1.5 AÊ relative to the equivalent residues of
either I-Ek or HLA-DR1. In fact, the conformation of thisfrom the b sheet platform at residues Tyr a9 and Gly
a9a in a b bulge conformation (Richardson et al., 1978). region is far more similar to class I structures, which
have a single additonal residue relative to I-Ak. AnalysisResidue Gly a9a adopts a left-handed turn conformation
that is unfavorable for all amino acids except glycine. of other I-A b chain sequences reveals that the deletion
seen here in I-Ak is shared by the I-Au,g7,f,s alleles.In I-Ak, the phenol ring of Tyr a9 projects backward
toward the P1 pocket, where it sits above the Ca atom Insertion at the End of the H2b-Helix of the
I-Ak b Chain (the b84a Insertion)of Gly a7. A similar b bulge most likely occurs for all I-A
and DQ-alleles, since residues Tyr a9 and Gly a9a are The least anticipated structural difference observed in
I-Ak occurs at the C-terminus of the b1 domain H2b helix.completely conserved and position a7 is always a small
residue. This region flanks the P1 binding pocket. The conforma-
tion of this region is characterized by an irregular patternThere are two significant restraints on the b1 strand
of the a1 domain that in part explain the insertion of the of helix-like turns, an ideal place for an amino acid inser-
tion to occur (Heinz et al., 1993). Previous sequencebulge. At the N-terminal end of the b1 strand, Asp a4
and His a5 form interactions that are conservative with alignments predicted that an insertion would occur be-
tween the b1 and b2 domains at position b94a (Kabat etthe interactions formed by these same residues in the
I-E and DR family. Without the insertion of the bulge, al, 1991). Nevertheless, comparison of the Ca positions
of I-Ak with I-Ek clearly indicates that a structural inser-hydrogen bonds formed between Asp a4 and the amide
nitrogen of Asn b19, as well as between the His a5 and tion occurs between residues b84 and b85 (I-Ak Lys b84a
in Figure 2). Therefore, the structural register of the I-AkAsp a27 side chains, would be lost.
A second reason for the a9a insertion is the nature of b chain is shifted by one residue relative to thepresumed
alignment, from the end of the H2b helix that Lys b84athe ab heterodimer chain-pairing. The I-Ak b chain has
a b sheet disrupting proline residue at position b13 (Fig- terminates to the beginning of the b2 domain (Glu b95).
There are two potential explanations for the insertionure 3). In I-E and HLA-DR heterodimers, the main chain
of b13 makes two antiparallel hydrogen bonds with the at I-Ak Lys b84a. The first concerns the nature of the
intramolecular interactions among residues b82±b91 ofmain chain of a9, neither of which is made in I-Ak. How-
ever, this second restriction is not absolute for all I-A the I-Ak b chain, which include eight hydrogen bonds.
Three of these hydrogen bonds are formed betweenheterodimers, since only the I-Ak and I-Au alleles have
a proline at b13; a glycine residue is present in all other threonine side-chain hydroxyl oxygen atoms and main-
chain carbonyl atoms (Thr b85 with b82, Thr b87 withalleles. Interestingly, mixed-isotyped class II molecules
are known to be functionally expressed in the H-2d b83, and Thr b89 with b85), while a fourth is formed
between the side chains of Ser b90 and Glu b86 (Figuremouse (i.e., I-Ed a chain/I-Ad b chain heterodimers), but
such mixed pairs are not efficiently formed in H-2k mice 3). These interactions are presumably highly stabilizing,
and not all could form in the absence of the bulge at(Sant et al., 1987; Spencer et al., 1993). It is tempting to
speculate that a dominant reason for the failure to form I-Ak b84a and the resulting register shift. A secondexpla-
nation for the insertion at Lys b84a is related to thean I-Ek a chain/I-Ak b chain heterodimer is the I-Ak Pro
b13, which would prevent the peptide-binding platform heterodimer pairing of the I-Ak/HEL complex. The I-Ak a
chain residue Arg a52 reaches underneath the peptidefrom forming properly when paired to an I-E a chain,
main chain to form a salt bridge with Glu b86 and hydro-which has no bulge. In the I-Ad b chain, position b13 is
gen bond to Thr b89. The I-A invariant Tyr a9 also makesa glycine residue, which would not present the same
a hydrogen bond with Glu b86. Furthermore, the peptidedifficulty, and thus the mixed-isotype pair can be
P1 anchor residue (Asp P1) forms a hydrogen bond withformed.
Thr b85. Thus, three b chain residues whose structuralDeletion between the H1 and H2a Helices
register is clearly dependent on the position of the inser-of the I-Ak b Chain (the b65±b66 Deletion)
tion (Thr b85, Glu b86, and Thr b89) are involved inComparison of the Ca traces of I-Ak with I-Ek (Figure 2)
heterodimer formation and peptide binding.indicates a region of significant structural divergence in
the H1 helix of the b chain and its junction with the
H2a (residues b59±b67). The analogous region in class Peptide Conformation
Despite the high degree of structural and sequence vari-I molecules (in the a2 domain) has been shown to adopt
peptide-dependent conformations (Fremont et al., 1992; ance of I-Ak with I-Ek and HLA-DR1, the HEL, hemoglobin
(Hb), and influenza virus hemagglutinin (HA) peptidesSmith et al., 1996). A structural alignment of I-Ak with
I-Ek and HLA-DR1 (in which nearest-neighbor Ca posi- that bind to them, respectively, are similar in their ex-
tended structures (Figure 4). Superposition of the P2±tions are considered equivalent) reveals that the best
Immunity
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Figure 2. Structural Alignment of I-Ak, I-Ek, and HLA-DR1
(A) Comparison of the peptide-binding platforms of I-Ak and I-Ek. The Ca positions of I-Ak (a1 domain in cyan, b1 domain in magenta, and
peptide in yellow) and I-Ek (all in gray, including the linker connected to the b chain N-terminus) are shown superimposed. The sites of insertion
(I-Ak a9a and b84a) and deletion (b65±b66) of the two structures relative to one another are highlighted by large red balls. The superposition
of the a5±a9, a10±a84, b5±b64, b67±b84, and b85±b94 segments yields an rms deviation of 0.93 AÊ . In addition to the insertions and deletions
Structure of an I-Ak/HEL Peptide Complex
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Figure 3. Polymorphic I-A Residues
(A) Location of polymorphic residues among
the I-Ak,u,g7,b,d,f,s,q alleles. The Ca ribbon of the
I-Ak peptide-binding domain is shown as a
thin tube, with a chain residues shown in cyan
and b chain residues in magenta. Nonpoly-
morphic residues adjacent to the insertions
at a9a and b84a are shown in gray. The a
and b chains of the I-Ak heterodimer form
extensive interactions with one another, with
many contacts arising from polymorphic resi-
dues. A total of 4260 AÊ 2 of surface area is
buried in the interface of the two chains, with
a1/b1 domain interactions contributing 62%
(2630 AÊ 2) of the total area.
(B) Solvent-accessible surface of the I-Ak/
HEL complex. The surface created by poly-
morphic I-A a chain residues is mapped in
cyan, the b chain in magenta, and the HEL
peptide in yellow. Prominent surface patches
are labeled according to the side chain that
contributes predominantly to the feature.
Polymorphic residues are underlined; pep-
tide residues are in bold. The I-A allelic poly-
morphisms mapped here onto the the struc-
ture of I-Ak reveals conserved patches of
solvent-accessible area in the a and b chains
straddling thepeptide, diagonal to the helices
(i.e., a22, a54, a57, a61, b73, b74, b76, and
b77). Variable I-A surface residues are pre-
sented predominantly near the ends of the
the peptide core: a40, a53, a55, b81, b84a,
b87, and b88 near the peptide N-terminus;
and a65, a68, a1, b63, b67, and b70 near
the peptide C-terminus. Thus the conserved
accessible surface presented by I-A mole-
cules is roughly coincident with the orienta-
tion observed crystallographically for TCRs
binding to class I molecules (Garboczi et al.,
1996; Garcia et al., 1996) and inferred for
class II based on mutational analysis (Sant'-
Angelo et al., 1996).
P11 main-chain atoms of HEL and Hb yields a root- conservative set of interactions originating from the
flanking helices than from the platform floor of the classmean-square (rms) deviation of 1.00 AÊ , while HEL devi-
ates from HA by 1.26 AÊ . The Hb peptide compares more II molecules. Relative to the other two peptides, HEL
rides considerably lower in the middle of the groovefavorably with HA, with a deviation of 0.85 AÊ .
The main-chainpaths of the three peptides are aligned (P3±P6) and reaches up higher toward solvent at the
end of the groove (P9±P11). Indeed, main-chain shiftsfar better laterally in the groove than they are longitudi-
nally. This can certainly be explained in part by the more as great as 2.0 AÊ can be seen in the middle of the groove
shown here, the I-Ak a chain has three additional residues at its N-terminal end that were not observed in the electron density maps. The
divergence of the I-Ek and I-Ak a chain N-terminal residues (a1±a4) is of unknown cause and consequence.
(B) A structure-based sequence alignment for the a1 and b1 domains of I-Ak, I-Ek (Fremont et al., 1996) and HLA-DR1 (Stern et al., 1994). The
secondary structure (Kabsch and Sander, 1983) of only I-Ak is presented above the sequence numbering, with b strands represented by solid
arrows and a helices by striped boxes. The sequences of I-Ek and HLA-DR1 that are identical to I-Ak are displayed as blank areas and absent
residues as asterisks. Amino acid side chains that lose appreciable solvent accessibility because of the binding of just the P1±P9 peptide
core for each structure are shown in shaded boxes.
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Figure 4. Comparison of Peptides Bound to Three MHC Class II Molecules
The conformation of HEL (yellow) bound to I-Ak is compared to Hb (cyan) bound to I-Ek (Fremont et al., 1996) and Flu HA (magenta) bound
to HLA-DR1 (Stern et al., 1994). The overlay is based on the Ca superposition of the a1 and b1 domains. This view is from the side of the
peptides, with anchor residues pointing downward. Note the dip of HEL in the center of the peptide and the rise upward at the C-terminal
end. The mean main-chain φ and c angles for the HEL peptide (P21±P10) are φ 5 290.08 6 16.68 and c 5 140.28 6 10.18; for Hb they are
φ 5 289.2 6 14.48 and c 5 139.08 6 15.78; and for HA they are φ 5 288.88 6 16.88 and c 5 143.48 6 16.08. Below the peptides and aligned
with the anchor residues is a graphical representation of the fractional buried surface area for each peptide side chain. The percentage side
chain buried was calculated (Connolly, 1993) as the solvent-accessible area of each side chain buried in the peptide-binding groove, divided
by the total surface area of that residue calculated for the peptide free in solution in the same conformation.
and greater than 3.0 AÊ at the C-terminus. Despite the main chain are formed directly with main-chain atoms
of I-Ak. Of particular note is the hydrogen bond betweendip and rise of HEL, all three peptides have similar main-
chain φ and c angles, which enforce a pronounced left- the amide nitrogen atom of Ile P4 and the carbonyl
oxygen atom of Tyr a9, a bond that can form only as ahanded helical twist to the emanating side chains. These
restricted angles are largely consistent with the φ and result of the b1-strand bulge of the a chain. In I-Ek and
HLA-DR1 peptide complexes, the side chain of Gln a9c angles adopted by typical b strand segments involved
in bidentate backbone interactions with amide side makes a hydrogen bond to the amide of P4.
In all, seven I-Ak side chains are involved in directchains (Jardetzky et al., 1996).
Peptide Main-Chain Hydrogen Bonding Network hydrogen bonding with the HEL backbone (Figure 5A).
Of these, four are conserved with I-E and HLA-DR heter-Promiscuous peptide binding by MHC molecules is es-
tablished by sequence-independent interaction with the odimers (Asn a62, Asn a69, His b81, and Asn b82),
whereas only three are conserved among I-A allelesextended peptide backbone. Of the 26 amide nitrogens
and carbonyl oxygens in HEL P22±P11, 12 form hydro- (Tyr b30, Glu b74, and Asn b82). This indicates that in
contrast to other MHC families, different I-A heterodim-gen bonds directly with I-Ak while 9 hydrogen bond with
water molecules, most of which in turn form extended ers may establish general peptide binding in a myriad
of ways. Indeed, variations in main-chain sequestrationhydrogen-bonding networks with I-Ak (Figure 5A). HLA-
DR and I-Ek make a similar number of hydrogen bonds of peptides by individual I-A alleles could increase the
diversity of global peptide binding by changing the ge-with the extended main chains of bound peptides (Stern
et al., 1994; Ghosh et al., 1995; Fremont et al., 1996; ometry with which peptide anchors enter into pockets
of the class II groove.Dessen et al., 1997). Three hydrogen bonds to the HEL
Structure of an I-Ak/HEL Peptide Complex
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Figure 5. Hydrogen Bonding Interactionsbe-
tween I-Ak and HEL
(A) Direct and water-mediated hydrogen
bonding between I-Ak and the main chain of
the HEL peptide. Tubes representing the
backbone and side chains of the I-Ak a1 do-
main are shown in cyan and b1 domain are in
magenta. HEL is shown in yellow, with side
chains beyond the Cb atom omitted. Oxygen
atoms are displayed in red and nitrogen
atoms in blue, with 11 water molecules dis-
played in silver. Participating I-Ak main chain
atoms are shown emanating from the back-
bone tubes. Putative hydrogen bonds are
represented as small gray balls connecting
atoms less than 3.2 AÊ apart with reasonable
geometry. I-Ak residues that serve in direct
hydrogen bonding and that are conserved in
I-Ek and HLA-DR1 peptide complexes are
shown with boxed labels (a53 main chain,
Asna62, Asn a69, His b81, and Asn b82).
(B) The extended hydrogen-bonding net-
works interacting with the hydrophilic HEL
residues in the P1, P6, and P9 pockets are
highlighted. Also shown are the interactions
of the carbonyl oxygens in the b1 strand bulge
of the I-Ak a chain (a9 and a9a).
Peptide Exposure and Burial to I-Ak has revealed a critical role for the C-terminal
flanking residues, with a significant number of clonesDespite their completely dissimilar sequences, the three
different peptides bound to I-Ak, I-Ek, and HLA-DR1 have dependent on Trp P11 (Carson et al., 1997).
a relatively conserved pattern of side-chain solvent ex-
posure (Figure 4). Four HEL side chains are entirely bur- I-Ak Peptide Binding Motif
Each MHC molecule has its own allele-specific motif foried in the I-Ak binding groove (Asp P1, Ile P4, Gln P6,
and Ser P9), while a fifth is 97.4% buried (Ile P7). A binding peptides. The imposition of sequence prefer-
ence is accomplished by extensive electrostatic andtotal of 878 AÊ 2 of HEL is buried in the I-Ak complex,
representing 63% of the total solvent-accessible area hydrophobic interactions of the peptide with polymor-
phic residues in the MHC binding groove. Indeed, 25 ofto a 1.4 AÊ probe (Connolly, 1993) of the free peptide given
the same conformation. The five dominantly buried HEL the 37 I-Ak residues that make van der Waals contact
with HEL vary among I-A alleles (Table 1). Three of theside chains account for 346 AÊ 2, or 39%, of the total
buried surface. An extremely similar pattern of buried five buried HEL side chains make extensive hydrophilic
interactions (Asp P1, Gln P6, and Ser P9), while twopeptide side chains emerges in the analysis of Hb and
HA, with the dominant sequestering of peptide anchors make predominantly hydrophobic contacts (Ile P4 and
Ile P7) (Figure 5B). A detailed description of each of theP1, P4, P6, and P9 and significant burial of P3 and P7
(for HA only). Residues in the core of the peptide that five binding pockets of I-Ak will follow.
P1 Pocketareknown tobe generally important for T cell recognition
exhibit the highest degree of exposure (P2, P5, and P8) Previous peptide-binding studies uncovered a critical
role for an aspartic acid residue in the binding of a(Allen et al., 1987; Reay et al., 1994; Stern et al., 1994).
The flanking residues of all three peptides (P22, P21, number of different peptides to I-Ak (Nelson et al.,
1996a). Substitution of HEL Asp P1 (residue 52) with anP10, and P11) also show a high degree of exposure,
with the largest area of exposure from Arg P10 and Trp alanine residue caused a 130-fold reduction in the ability
to compete for I-Ak binding and reduction of the SDSP11 of HEL (Figure 3B). Interestingly, a recent study of
TCR recognition of HEL 48±63 and its analogs bound stability of the complex from 96% to 6%. Asp P1 in
Immunity
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Table 1. Specific Interactions of HEL with I-Ak
HEL Hydrogen Bonds van der Waals contacts
Ser P-2 (50) O Arg a53 N Leu a51, Arg a52, Arg a53, Lys b84a, Thr b85
Og H20
Thr P-1 (51) N H2O Arg a53, His b81
O His b81 Ne2
Asp P1 (52) N Arg a53 O Phe a24, Arg a52, Arg a53, Phe a54, Asn b82, Thr b85
O H2O
Od1 Arg a52 Nh2
Od1 Thr b85 Og1
Od2 Arg a52 Ne
Tyr P2 (53) N Asn b82 Od1 Tyr a9, Phe a24, Thr b77, Val b78, His b81, Asn b82
O Asn b82 Nd2
OH H2O
Gly P3 (54) N H2O Tyr a9, Tyr a22, Phe a24, Phe a54, Val b78
O H2O
Ile P4 (55) N Tyr a9 O Tyr a9, Asn a62, Phe b11, Pro b13, Leu b26, Ile b28, Glu b74, Val b78
O H2O
Leu P5 (56) N Glu b74 Oe2 Asn a62, Phe b11, Arg b70, Glu b74
O H2O
Gln P6 (57) N Asn a62 Od1 Thr a11, Asn a62, Thr a65, Gly a66, Asn a69, His b9, Phe b11, Tyr b30
O H2O
Ne2 Asn a62 O
Oe1 H2O
Ile P7 (58) N Tyr b30 OH Thr a65, Asn a69, Tyr b30, Tyr b47, Trp b61, Tyr b67, Arg b70
O Asn a69 Nd2
Asn P8 (59) N H2O Thr a65, His a68, Asn a69 Trp b61
Ser P9 (60) N Asn a69 Od1 His a68, Asn a69, Ile a72, Arg a76, Asp b57, Trp b61
O His a68 Ne2 Asp b57, Trp b61
Og Asp b57 Od1
Og H2O
Arg P10 (61) O H2O Ile a72, Tyr b60
Nh1 H2O
Nh2 H2O
Trp P11 (62) His a68, Glu a71, Ile a72, Lys a75
I-A polymorphic residues are underlined.
the HEL peptide fits exquisitely into the I-Ak P1 pocket, in naturally processed peptides eluted from I-Ak, al-
though asparagine residues have also been observedforming a salt bridge with the edge of the Arg a52 gua-
nidium as well as a hydrogen bond with Thr b85 (Figure (Nelson et al., 1992; Marrack et al., 1993) (Figure 6).
However, the substitution of Asp P1 in HEL with an5B). Mutation analysis of the I-Ak a chain indicated that
an alanine substitution of Arg a52 resulted in a signifi- asparagine residue causes a change in peptide binding.
For example, the complex is more sensitive to SDS de-cant decrease in HEL 48±62 binding (Nelson et al.,
1996b). The aliphatic portion of the Asp P1 side chain naturation (Nelson et al., 1996a) and is less reactive with
a monoclonal antibody specifically directed against I-Ak/makes hydrophobic interactions with both Phe a24 and
Phe a54. The extended P1 pocket hydrogen bonding HEL (Dadaglio et al., 1997). An explanation for these
changes is apparent: an asparagine residue as the P1network includes the side chains of Tyr a9, Glu b86, Thr
b89, and Ser b90. anchor would unfavorably interact with Arg a52 in the
absence of a subtle rearrangement of the pocket.Clearly, the creation of the P1 pocket as an aspartic
acid residue binding site is dependent on the insertion P4 Pocket
Although not as tightly restricted as the P1 anchor, dis-in both the a and b chains of I-Ak, as has been discussed.
In contrast to the shape of many other pockets within tinctly preferred residues are found in the P4 positions
of naturally processed self-peptides (Figure 6). The P4MHC binding grooves that can be described as sloppy
or accommodating of their anchor residue, the fit of positions of most of the aligned self-peptides are me-
dium-sized hydrophobic residues (isoleucine, valine,aspartic acid into the I-Ak P1 pocket is nearly perfect
(Figure 6). The dominant anchor residues of HLA-DR1 and leucine), although Asn also occurs frequently. In
this respect the I-Ak P4 pocket is similar to the I-Ek P4and I-Ek binding peptides are tyrosine and lysine resi-
dues in the P1 and P9 positions, respectively. In both pocket in that hydrophobic residues are preferred and
yet a large number of substitutions are tolerated in thecases, the accepting pockets use water molecules to
mediate hydrogen bonding from the anchor residue to loose-fitting, hydrophobic P4 cavity (Reay et al., 1994;
Fremont et al., 1996). In the I-Ak/HEL complex, the Ileclass II residues in the groove. The high-resolution struc-
ture of I-Ak/HEL indicates that there are no water mole- P4 side chain makes hydrophobic contact with I-A poly-
morphic residues Phe b11, Pro b13, Leu b26, Ile b28,cules associated with the elaborate P1 pocket hydro-
gen-bonding network. This zen-like perfection may well and Val b78. The I-A invariant Glu b74 also makes exten-
sive van der Waals contact with the Ile P4 side chain,account for the overwhelming representation of Asp P1
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atom would be perfectly poised to donate a proton to
Gln P6 Oe1, although a similar carbon±oxygen clash
would then occur between His b9 and Tyr b37. Notwith-
standing these caveats, the perplexing aspect of the P6
hydrogen-bonding scheme is that glutamic acid is the
apparently preferred residue. With Glu P6 isosterically
occupying the same position as HEL Gln P6, a carboxyl-
ate oxygen would be situated 2.9 AÊ from the carbonyl
oxygen of Asn a62, a situation that would appear unlikely
unless the glutamic acid side chain was protonated.
This situation is reminiscent of the P6 pocket binding
scheme in I-Ek (Fremont et al., 1996). Like I-Ak, the bind-
ing motif for I-Ek includes a P6 preference for glutamic
acid and glutamine residues, although the geometry and
chemistry of the P6 pockets are completely different.
The base of the I-Ek P6 pocket is composed of two
acidic residues (Glu a11 and Asp a66, conserved in all
I-E and DR alleles), which interact with a buried Glu P6
residue in a manner that suggests that one or more
carboxylate groups are necessarily protonated. This
Figure 6. I-Ak Pockets and Anchors clustering of acidic residues in the P6 pocket clearly
The solvent-accessible surface of the I-Ak peptide-binding groove could contribute to the observed pH dependence of
is displayed as a blue dotted surface; HEL P1±P9 is shown with van
peptide binding to the I-Ek molecule (Reay et al., 1992).der Waals spheres representing the atoms. Aligned under the HEL
The situation in I-A is not nearly as well defined. I-Apeptide are the sequences of several naturally processed peptides
residues a11 and a66 are both polymorphic, as are Histhat have been recovered from I-Ak±expressing cells (Nelson et al.,
1992; Marrack et al., 1993). The primary deep pockets P1, P4, P6, b9 and Tyr b37, which make up the P6 pocket hydrogen-
and P9 are highlighted in blue, and the surface pocket P7 is high- bonding scheme in the I-Ak/HEL complex. Like with I-Ek,
lighted in blue stripes. the possibility that the P6 pocket of I-Ak influences the
pH profile for the binding of some peptides is intriguing
(Harding et al., 1991).
and one could speculate that this residue may be critical P7 Pocket
in the binding of an Asn at P4. Another possibility for Although Ile P7 is predominantly buried in the I-Ak struc-
Asn P4 side-chain interactions are the exposed main- ture, there appears to be little restriction on the residue
chain atoms of Tyr a9 and Gly a9a, made possible by that occupies this position. A wide diversity of residues
the a chain b1 strand bulge and the dip in the peptide is found in self-peptides at the P7 position, with all
backbone in this region (Figure 5). classes represented with the exception of those posi-
P6 Pocket tively charged (Figure 6). Pocket P7 in the I-Ak structure
In the I-Ak peptide-binding motif, the residue with the is best described as a surface or shallow pocket, in that
second most restricted sequence among self-peptides the side chain projects sideways toward the b chain a
is P6, which consists predominantly of glutamic acid helix rather than downward toward the platform of the
and glutamine residues. The HEL Gln P6 side chain peptide-binding groove (Figure 6). The side chain of Ile
makes significant hydrophobic contact with Phe b11. P7 makes hydrophobic contact with Tyr b47, Trp b61,
However, the hydrogen-bonding interactions of the Gln and Tyr b67. The extensive interactions of Ile P7 with
P6 side chain are unusual and ambiguous. In our I-Ak/ Trp b61 may well be responsible for the inability of Trp
HEL model, the Gln P6 Ne2 atom inserts into the a chain b61 to form a hydrogen bond with the peptide main
H2 helix, hydrogen bonding with the carbonyl oxygen chain. Tyr b67, which is common to all alleles with the
of Asn a62 (Figure 5B). The Gln P6 Oe1 atom forms a b65±b66 deletion, may act as a P7 pocket flap or tum-
hydrogen bond with a buried water molecule that in turn bler, allowing a broad diversity of interactions to occur
hydrogen bonds with His b9 Nd1. at this site.
There is a significant caveat to this description of P9 Pocket
the P6 pocket. In crystallographically derived electron The consensus motif for the P9 position of I-Ak binding
density maps there are ambiguities in the absolute con- peptides is a small residue, typically a serine. Compared
figurations of glutamine, asparagine, and histidine side to peptides bound to I-Ek or HLA-DR1, the main chain
chains. Typically, these ambiguities are resolved by of the HEL peptide is situated higher in the groove at
building a model with idealized chemical interactions the P9 pocket (Figure 4). The size and shape of the
and uniform temperature factors (B values). These ap- pocket create a fairly loose fit for Ser P9 of HEL (Figure
proaches were applied in the case of the P6 pocket 6), and some larger residues (e.g., threonine) should be
hydrogen bonding scheme, and yet one unusual chemi- easily accommodated. The Ser P9 side chain of HEL
cal interaction remains: a 3.0 AÊ distance between the is involved in an elaborate hydrogen-bonding scheme
Gln P6 Oe1 atom and the His b9 Ce1 atom. This type of involving a number of residues in and around the P9
interaction is not very uncommon for histidine residues pocket (Figure 5B). Direct hydrogen bonds are formed
in some proteins (Derewenda et al., 1994). Nevertheless, between the Ser P9 hydroxyl oxygen atom and Asp b57
as well a buried water molecule located at the base ofif the His b9 imidazole ring were flipped 1808, the Ne2
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Table 2. Data Collection and Refinement Statistics
Crystal space group: P41212
Cell parameters (AÊ ): a 5 b 5 112.25; c 5 99.72
Data processing
Observations to 1.9 AÊ 198,306
Unique reflections 48,139
Completeness (%) 95.7 (96.6)
I/s 11.7 (2.5)
Rsyma 0.050 (0.27)
Refinement
Data range (AÊ ) 10.0±1.9
Reflections (F . 0) 47,865
Completeness (%) 95.2 (96.1)
Reflections in Rfree set 2410 (293)
Nonhydrogen atoms 3541
Solvent molecules 369
rms D bond lengths (AÊ )b 0.009
rms D bond angles (degrees) 2.0
rms D dihedral angles (degrees) 25.1
rms D improper angles (degrees) 1.18
rms D main-chain bond B-factors (AÊ 2) 1.47 [1.5]
rms D main-chain angle B-factors (AÊ 2) 2.53 [2.0]
rms D side-chain bond B-factors (AÊ 2) 1.65 [2.0]
rms D side-chain angle B-factors (AÊ 2) 2.67 [2.5]
Est. coord. error from Luzzati plot (AÊ ) 0.25
Rcryst (%)c 21.4 (35.7)
Rfree (%)d 26.3 (39.2)
Values in parentheses are for data in the highest-resolution shell (1.99±1.90 AÊ ).
a Rsym 5 S| I 2 ,I.|/SI, where I is the observed intensity and ,I. is the average intensity for multiple observations of symmetry-related
reflections.
b Root mean square deviations (rms D) are relative to idealized values. Numbers in brackets correspond to sigma target values for B factors.
c Rcryst 5 S| Fo| 2 |Fc|/SFo, where Fo is the observed structure factor amplitude and Fc is the calculated structure factor amplitude for the refined
atomic model. Rcryst is reported for all data not in the Rfree set, with F . 0 between 10 and 1.9 AÊ .
d Rfree is calculated as Rcryst for a test set of data not used in refinement.
the pocket. This water molecule in turn hydrogen bonds into I-Ak pockets P4, P6, P7, and P9. Nevertheless, as
with other MHC allele-specific motifs, peptides usingwith Tyr b37, which plays a role in the chemistry of
the P6 pocket, as discussed. The Asp b57 carboxylate alternative anchor residues will still bind and be pre-
sented, albeit less efficiently (Nelson et al., 1996a).group forms a salt bridge with Arg a76 underneath the
peptide main chain, and its replacement with other resi- The structure of the I-Ak/HEL complex indicates three
residues in the core of the HEL peptide that are highlydues has been implicated in autoimmune diabetes in
both mice and humans (Acha-Orbea and McDevitt, exposed to solvent. These are the same residues that
have been described previously as TCR contacts: P31987; Todd et al., 1987). Replacement of Asp b57 with
a serine in I-Ag7 thus has the potential of significantly (Tyr 53), P5 (Leu 56), and P8 (Asn 59) (Allen et al., 1987).
However, to our surprise, the C-terminal flanking resi-altering the motif-restricted P9 residue.
dues of HEL rise high out of the peptide-binding groove,
in accordance with a recent study showing T cell recog-Conclusions
nition of the 48±62 peptide but not with the 48±61 pep-Our structural analysis of the I-Ak/HEL complex reveals
tide (Carson et al., 1997). Thus, it appears that positionseveral structural elements unique to the I-A family of
P11 can also act as a direct T cell contact residue.class II molecules. Bulges in the main chain of the class
II moleculeoccur in the firststrand of the a1 domain in the
Experimental ProceduresP4 pocket and in the b1 domain helical region adjacent to
the P1 pocket. A two-residue deletion in a highly solvent-
Design and Construction of the Covalent I-Ak Complexexposed region of the b1 domain helical region, common The extracellular domains of I-Ak were expressed in CHO cells as
among I-Ak,u,g7,f,s alleles, is also characterized. These fea- a GPI-linked surface protein (Wettstein et al., 1991) with the HEL
tures, along with the polymorphic residues lining the peptide covalently linked to the N-terminus of the b chain (Kozono
et al., 1994). This GPI-linked class II could be cleaved from thepeptide-binding groove, firmly establish the main princi-
cell surface with phosphatidylinositol phospholipase C (PIPLC). Theples responsible for I-Ak pepide binding. The argument
cDNAs for I-Aak and I-Abk 47±62 (Viner et al., 1996) were truncatedthat an aspartic acid residue is the dominant peptide
after the codons for Met a186 and Arg b196, respectively, and fusedanchor required for high-affinity binding to I-Ak is con-
by overlap-extension PCR to the signal sequence of the human
vincingly argued by the features of the P1 pocket. We placental alkaline phosphatase (residues 476±513). The primers
also have been able to identify structural preferences used for this purpose were as follows: aU30408, GCC GGC GGG
GGG CGC CAG CAT GGG GGC TGG AAT CTC AGG; bU30394, GCCfor the sequestering of four additional anchor residues
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GGC GGG GGG CGC CAG CCG GGC AGA CTC GGA CTG; APD, scaled with SCALA and merged with AGROVATA (Collaborative
Computing Project 4 [CCP4], Daresbury Laboratory, Warrington,CTG GCG CCC CCC GCC G; and APU, GGG TCT AGA AGG TTC
CAT GGC AGG ACC TC. The PCR products I-Aak-GPI and I-Abk UK), with Wilson scaling applied to the final output structure factor
amplitudes.47±62-GPI were cloned into expression vectors pCEP4 and
pCDNA3, respectively. The protein products of both constructs are
thus expected to have at their C-terminal ends the following se- Structure Determination and Refinement
quence: Met a186 or Arg b196±LAPPAGTTD. A phosphatidylinositol The structure of I-Ak/HEL was determined by molecular replacement
moiety is expected to be covalently attached to the C-terminal using AMoRe (CCP4). The coordinates of I-Ek/Hb (PDB accession
aspartic acid residue. In the I-Abk 47±62-GPI construct, the se- code 1IEA; Fremont et al., 1996) were used as the search probe run
quence-encoded N-terminal to the natural b chain is as follows: against the Raxis II data for the I-Ak/HEL complex. Mismatched
GNSER-SG-TDGSTDYGILQINSRW-GGGGSLVPRGSGGGGSGS± residues in the model were truncated to alanine. The cross-rotation
Phe b7, where the first segment is the natural b1±b5 of the I-Abk function yielded a peak orientation 3.5 s above the mean of the map.
chain, followed by a two residue insert, and then HEL residues Translation functions were run in all possible primitive tetragonal
47±62, followed by a flexible linker with an encoded thrombin cleav- enantiomorphs, with the highest signal (correlation coefficient 5
age site. 25.2%, R value 5 49.6% for all 8±4AÊ data) unambiguously in space-
group P41212, consistent with the observed systematic absences in
Cell Line the data. Rigid-body refinement of the three independent domains
The CHO.A2 cell line was obtained by electroporation of CHO cells of I-Ek (a1/b1, a2, and b2) against the I-Ak/HEL data yielded an R value
(ATCC CCL 61) with the constructs described above. CHO cells of 44.7% for 8±4 AÊ resolution data. Extensive model rebuilding of
(2.5 3 106) grown in a-minimal essential medium (a-MEM) supple- I-Ak/HEL was performed using the modified version (California Insti-
mented with 10% fetal calf serum (FCS) were resuspended in 300 tute of Technology/University of California, San Diego) of TOM
ml of media added with 10 ml 103 HEPES buffer (200 mM HEPES, (Jones, 1978). Both 2Fo2Fc and Fo2Fc omit maps in which roughly
1000 mM NaCl, 50 mM KCl), 40 mg of salmon sperm carrier DNA, 30 residues were left out of the phase calculations were used for
2 mg of pCDNA3 I-Abk-47±62-GPI, and 10 mg of pCEP4 I-Aak-GPI model building. Atomic refinement was carried out using restrained
in water to a final volume of 400 ml and placed in a 2 mm gap least-squares and simulated annealing protocols as implemented
electroporation cuvette. After chilling on ice for 5 min, the cells were in XPLOR (Brunger et al., 1987). The final stages of refinement were
electroporated using an Electro Cell Manipulator 600 (BTX, San carried out using a bulk-solvent correction in order to include low-
Diego, CA) set at 600 mF, 230 V with a 129 V resistance. A typical resolution data. Atotal of 380amino acids were built into the electron
pulse lasted 6 min. The cells were transferred to 50 ml of a-MEM density maps out of a total heterodimer of 438 residues including
supplemented with 10% fetal calf serum and placed at 378C in the covalent peptide. For the a chain, the first 3 residues (a1a±a1c)
a 5% CO2 incubator. Twenty-four hours after electroporation the and the last 14 residues (a182±a195) could not be accurately traced.
medium was changed, and G418 (Sigma, St. Louis, MO) was added For the b chain, 10 residues N-terminal to the HEL peptide (P212±
at 0.6 mg/ml. After 10 days the cells were stained with anti-I-Ak P23) and 16 residues in the covalent linker (P12±P27) were disor-
monoclonal antibody 40F as described (Dadaglio et al., 1997), and dered, as were 15 residues at the C-terminal tail of the chain (b191±
the brightest 5% were sorted and expanded. This procedure was a205). The electron density for peptide residues P10 and P11 (HEL
repeated until a population with a stable expression was obtained. 61±62) was very weak, but the general location of the main chain
and side chains was confirmed in two independent data sets. Never-
Protein Expression and Purification theless, the atomic positions are probably less accurate than the
The CHO.A2 cells were grown in a-MEM supplemented with 5% rest of the structure. The first two residues that could be built in
heat-inactivated calf serum in 2-liter roller bottles and harvested by the b chain (Gly b5 and Ser b6) are actually cloning artifacts of the
centrifugation at 2000 rpm (675 3 g) for 10 min in a GS3 rotor linker construction, since these residues are Arg b5 and His b6 in
(Sorvall). The pellet was resuspended at 2.5 3 106 cells/ml in Hanks' the natural I-Ak sequence. The final model includes HEL residues
balanced salt solution and treated with 0.5 mg/ml PIPLC prepared 50±62 (P22±P11); I-Ak a chain residues a1±a181; b chain residues
as described (Low, 1992) for 4 hr at 378C. The cells were spun down b5±b190; 369 water molecules; and three GlcNAc residues attached
and the supernatant was loaded on a 40F-Sepharose-4B column. to residues Asn a78, Asn a118, and Asn b19. Refinement of this
The column was extensively washed with phosphate-buffered sa- model against all data between 10 and 1.9 AÊ resolution yielded an
line, and the I-Ak/HEL complex was eluted with 120 mM glycine (pH R value of 21.4% and an Rfree of 26.3% (5% test set) with good
3.5), 0.9% NaCl. The eluate was immediately neutralized with 1 M geometry (Table 2).
Tris (pH 8.0). This procedure yielded 1.2 mg out of 1011 cells as Coordinates of the I-Ak/HEL complex have been deposited in the
determined by a Biorad protein assay. The final protein was concen- PDB under accession code 1IAK and are otherwise available via
trated to 10 mg/ml in 10 mM HEPES (pH 7.5). e-mail (fremont@immunology.wustl.edu).
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Data Collection and Processing
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